Yamamoto Y - Search Results

1

Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.

Hayashi M, Yamamoto Y, Ibusuki M, Fujiwara S, Yamamoto S, Tomita S, Nakano M, Murakami K, Iyama K, Iwase H. Hayashi M, et al. Among authors: yamamoto y, yamamoto s. Ann Surg Oncol. 2012 Sep;19(9):3042-9. doi: 10.1245/s10434-012-2343-1. Epub 2012 Apr 3. Ann Surg Oncol. 2012. PMID: 22476757

2

Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.

Yamamoto Y, Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S, Ogawa M. Yamamoto Y, et al. Oncol Rep. 2003 Jul-Aug;10(4):791-6. Oncol Rep. 2003. PMID: 12792725

3

[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].

Yamamoto Y, Kawazoe T, Iwase H. Yamamoto Y, et al. Gan To Kagaku Ryoho. 2005 Oct;32(10):1415-9. Gan To Kagaku Ryoho. 2005. PMID: 16227740 Japanese.

4

[Two cases of stage IV breast cancer with severe hypercalcemia].

Ohsako T, Yamamoto Y, Kawazoe T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O, Sakamoto N, Iwase H. Ohsako T, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2006 Feb;33(2):223-6. Gan To Kagaku Ryoho. 2006. PMID: 16484860 Japanese.

5

Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.

Kurebayashi J, Yamamoto Y, Kurosumi M, Okubo S, Nomura T, Tanaka K, Sonoo H. Kurebayashi J, et al. Among authors: yamamoto y. Anticancer Res. 2006 Jan-Feb;26(1B):695-701. Anticancer Res. 2006. PMID: 16739340 Free article.

6

A case report of paraneoplastic neurological syndrome associated with occult breast cancer.

Kawasoe T, Yamamoto Y, Okumura Y, Iwase H. Kawasoe T, et al. Among authors: yamamoto y. Breast Cancer. 2006;13(2):202-4. doi: 10.2325/jbcs.13.202. Breast Cancer. 2006. PMID: 16755118 Free article.

7

Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.

Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H. Zhang Z, et al. Among authors: yamamoto y. Clin Cancer Res. 2006 Nov 1;12(21):6410-4. doi: 10.1158/1078-0432.CCR-06-1347. Clin Cancer Res. 2006. PMID: 17085653

8

[Prediction for efficacy of endocrine therapy for breast cancers using gene profiling].

Iwase H, Yamamoto Y. Iwase H, et al. Among authors: yamamoto y. Nihon Rinsho. 2007 Jun 28;65 Suppl 6:549-54. Nihon Rinsho. 2007. PMID: 17682209 Review. Japanese. No abstract available.

9

Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.

Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H. Yamamoto Y, et al. Breast Cancer Res Treat. 2008 Aug;110(3):465-75. doi: 10.1007/s10549-007-9742-1. Epub 2007 Sep 6. Breast Cancer Res Treat. 2008. PMID: 17805961

10

[Treatment guideline for breast cancer and SERM-treatment].

Iwase H, Yamamoto Y, Kawasoe T. Iwase H, et al. Among authors: yamamoto y. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:636-40. Nihon Rinsho. 2007. PMID: 18159717 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,338 results

Search Page

Filters